Skip to main content

Peer Review reports

From: Denosumab for treating periprosthetic osteolysis; study protocol for a randomized, double-blind, placebo-controlled trial

Original Submission
19 Feb 2016 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
15 Apr 2016 Editorially accepted
23 Apr 2016 Article published 10.1186/s12891-016-1036-5

You can find further information about peer review here.

Back to article page